Atlas Trials

Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M

Clinical trial NCT02830763 · TERMINATED

Trial details

NCT number
NCT02830763
Sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV)Neutral Lipid Storage Disease With Myopathy (NLSD-M)
Start date
2016-09-05
Primary completion
2019-01-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.